ArticlePublished 3 May 2019
Synthesis and Pharmacological Screening of New Thienopyridines for the treatment of AlzheimerÃ?¢Ã?â?¬Ã?â?¢s disease
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Alzheimer is a multitargeting brain-hitting disease. The need to prepare and screen new agents is endless. Novel thienopyridine-tacrine analogues 4a,b – 8a,b and 9 have been designed, synthesized and biologically screened against cholinesterase inhibition activity. Two compounds 7a and 7b were found active. Compound 7b exceeded tacrine as a cholinesterase inhibitor. The docking studies explained this activity as compound 7b exhibited similar binding affinity to the acetylcholinesterase enzyme as with tacrine in addition to an extra hydrogen bonding
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalDer Pharma Chemica
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Afaf El-Malah”
- BylineArticles whose byline prints “Zeinab Mahmoud”
- BylineArticles whose byline prints “Mai A. AbdEl Fattah”